Confusion over shifting Centers for Disease Control and Prevention COVID-19 vaccine recommendations are reigniting questions ...

The strong immune response was confirmed in CHIKV-naïve children with a 96.5% seroresponse rate (full dose) at Day 180. VLA1553 was well tolerated in children aged one to eleven years regardless of ...

Chikungunya, a mosquito-borne virus, has been detected at higher-than-expected rates among U.S. travelers from the Indian state. To reduce infection risk, the CDC urges travelers to adopt mosquito ...